Longaeva Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Longaeva Partners's VRTX Position: Q2 2026 in Review
Longaeva Partners increased its Vertex Pharmaceuticals (VRTX) stake by 21% in Q2 2026, buying an estimated $2.37M and bringing the position to 30,279 shares worth $15M. The position accounts for 0.33% of the portfolio, ranked #87.
Longaeva Partners first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Longaeva Partners held 30,279 shares of Vertex Pharmaceuticals worth $15M as of Q2 2026.
- Longaeva Partners bought 5,344 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.37M.
- Vertex Pharmaceuticals made up 0.33% of Longaeva Partners's portfolio in Q2 2026, its #87 holding.
- Longaeva Partners first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.